AVITA Medical, Inc. (RCEL) stock
RCELNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as AVHHL
$15.22−0.41 (-2.62%)
Close on Nov 16, 2026Market cap $470.71MP/E –Yield –
AVITA Medical profit margin
Profit margin (net margin) is net income as a percentage of revenue.
AVITA Medical's profit margin for the twelve months ending Jun 30, 2026 was -57.0%. For fiscal 2025 it was -67.8%, against -96.3% the year before. The highest annual figure on record is -67.8% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -67.8% | +28.4 |
| FY2024 | Dec 31, 2024 | -96.3% | −25.7 |
| FY2023 | Dec 31, 2023 | -70.6% | +20.4 |
| FY2021 | Jun 30, 2021 | -90.9% | +203.7 |
| FY2020 | Jun 30, 2020 | -294.7% | +163.9 |
| FY2019 | Jun 30, 2019 | -458.6% | +912.3 |
| FY2018 | Jun 30, 2018 | -1370.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -35.3% | +18.6 |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -55.1% | +19.7 |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -66.0% | −3.0 |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -77.3% | +5.6 |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -53.9% | +47.4 |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -74.9% | +93.2 |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -63.0% | −13.2 |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -82.9% | −19.1 |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -101.3% | −13.0 |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -168.0% | −80.6 |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -49.8% | −4.0 |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -63.8% | +4.6 |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -88.4% | +22.2 |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -87.4% | +114.7 |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -45.8% | +287.3 |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -68.4% | +319.7 |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -110.5% | +211.7 |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -202.1% | −92.4 |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -333.1% | −22.7 |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -388.1% | −26.6 |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -322.2% | +280.3 |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -109.7% | +1761.7 |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | -310.4% | – |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | -361.5% | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | -602.5% | – |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | -1871.4% | – |
See a number that looks wrong?